Panbela Therapeutics, Inc. Profile Avatar - Palmy Investing

Panbela Therapeutics, Inc.

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pa…

Biotechnology
US, Waconia [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Panbela Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Panbela Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Panbela Therapeutics, Inc..

End of PBLA's Analysis
CIK: 1029125 CUSIP: 69833W107 ISIN: US69833W4042 LEI: - UEI: -
Secondary Listings
PBLA has no secondary listings inside our databases.